Autopsy report · NCT02730715
Effect of Thymoglobulin Versus Basiliximab on Regulatory T Cell Function in Live Donor Kidney Transplant Recipients
Cause of deathSlow enrollment
“Insufficient amount of T Cell collection”
Life of this trial
- Registered 5 years 4 months after it had already started.
- Ran for about 9 years 5 months before it stopped.
- 30 participants planned (an estimate, not an actual count).
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- University of Pennsylvania
- Sponsor type
- University, hospital or other
- Conditions
- KIDNEY TRANSPLANTATION
- Interventions
- Basiliximab; Thymoglobulin
- Participants
- 30 (planned, not actual)
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.